There were 1,457 press releases posted in the last 24 hours and 405,941 in the last 365 days.

Gamma Knife Market: Brain Metastasis Segment to Expand at 9.2% CAGR through 2025

Gamma Knife market is expected to be amplify at a brisk pace through 2025, owing to its effectiveness in treating brain metastasis, cancer, trigeminal neuralgia

VALLEY COTTAGE, NEW YORK, UNITED STATES, August 17, 2015 /EINPresswire.com/ -- Future Market Insights (FMI), in its research report, titled, “Gamma Knife Market: Global Industry Analysis and Opportunity Assessment 2015-2025,” provides key insights on the growing use of Gamma Knife in treating brain disorders and cancers.

Future Market Insights has segmented the global Gamma Knife market on the basis of disease indication into brain metastasis, cancer, arteriovenous malformation, trigeminal neuralgia, and others.

The brain metastasis segment accounted for 68.4% of the overall Gamma Knife market in 2014. According to FMI, this segment is anticipated to witness a compound annual growth rate (CAGR) of 9.2% during the forecast period 2015-2025 and reach a valuation of US$ 285.7 Mn.

The use of Gamma Knife in treating cancer is gaining traction in the healthcare sector. Gamma Knife is non-invasive in nature, owing to which it is being widely used in treating elderly patients. The cancer segment accounted for 10.2% of the overall Gamma Market in 2014; FMI estimates it to hold a market share of 10.9% by the end of forecast period.

Browse Research Report on Global Gamma Knife Market: http://www.futuremarketinsights.com/reports/gamma-knife-market

Gamma Knife is also being used to treat arteriovenous malformation (AVM), an abnormal connection between veins and arteries. AVM is usually congenital and currently not much information is available on the genetic transmission patterns of AVM. According to FMI’s research, the arteriovenous segment of the Gamma Knife market is expected to amplify at a CAGR of 7.6% during the period 2015-2025.

Use of Gamma Knife in treating Trigemial neuralgia, also known as prosopalgia, is also gaining acceptability in the healthcare sector. According to FMI, this segment of Gamma Knife market is projected to expand at a CAGR of 7% during the forecast period and reach a valuation of US$ 32.9 Mn by 2025.

FMI’s research report has also segmented the Gamma Knife market on the basis of anatomy. The segments on the basis of anatomy include head, neck, and other body parts. Among these, use of Gamma Knife treatment is predominant in treating disorders of the head.

The head segment accounted for a share of 88.1% in 2014; FMI expects this segment to amplify at a CAGR of 9.2% during the forecast period and reach a valuation of US$ 364.8 Mn.

Get More Insights on Healthcare, Pharmaceuticals and Medical devices Market on http://www.futuremarketinsights.com/reports/category/healthcare-pharmaceuticals-medical-devices

Increasing adoption of Gamma Knife treatment in treating disorders of the neck are fuelling this segment of the market. FMI estimates this segment to amplify at a CAGR of 7.7% during the forecast period. This segment is also anticipated to witness an absolute $ opportunity of over US$ 0.1 Mn per year.

The ‘other body parts’ segment in FMI’s research report is projected to expand at a low double-digit CAGR during the forecast period. This segment accounted for a market share of 7.8% of the global Gamma Knife market in 2014.

FMI has also segmented the global Gamma Knife market on the basis of geography. Key regions covered in the report include Asia Pacific (APAC), Europe, Latin America, Middle East and Africa (MEA), and North America.

For more insights on Gamma Knife Market, you can request a sample report at http://www.futuremarketinsights.com/reports/sample/rep-gb-589

North America was the most lucrative market in 2014, and FMI expects it to amplify at a CAGR of over 7% during the forecast period. The research and development (R&D) activities on development of Gamma Knife have been going on at a fast pace in the region. Furthermore, awareness among the benefits of Gamma Knife is high among healthcare professionals in the region.

FMI Latest Insights:

Continuous Glucose Monitoring Systems Market: http://www.futuremarketinsights.com/reports/continuous-glucose-monitoring-systems-market

Animal Healthcare Market: http://www.futuremarketinsights.com/reports/animal-healthcare-market

Automated CPR Devices Market: http://www.futuremarketinsights.com/reports/automated-cpr-devices-market

About Us

Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights and an aerial view of the competitive framework and future market trends.

Our research services cover global as well as regional emerging markets such as GCC, ASEAN, and BRICS. Our offerings cover a broad spectrum of industries including Chemicals, Materials, Energy, Technology, Healthcare, and Retail. FMI’s operating model blends cross-disciplinary research experience to deploy in-depth, insightful and actionable research.

Contact

Mr. Sudip Saha
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
T (UK): + 44 (0) 20 7692 8790
F: +1-845-579-5705
Email: sales@futuremarketinsights.com
Website: www.futuremarketinsights.com

Abhishek Budholiya
Future Market Insights
+1-347-918-3531
email us here

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.